Different Growth Patterns of Non-Small Cell Lung Cancer Represent Distinct Biologic Subtypes

Annals of Thoracic Surgery

Volumn 85, Issue 2, 2008, Pages 395-405

  Sardari Nia, Peyman ^a   Colpaert, Cecile ^a   Vermeulen, Peter ^a   Weyler, Joost ^a   Pezzella, Francesco ^b   Van Schil, Paul ^a   Van Marck, Eric ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE FREE SURVIVAL; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SURGICAL TECHNIQUE; TUMOR CELL; TUMOR VASCULARIZATION;

ADULT; AGED; BIOPSY, NEEDLE; CARCINOMA, NON-SMALL-CELL LUNG; CELL GROWTH PROCESSES; CELL PROLIFERATION; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOVASCULARIZATION, PATHOLOGIC; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS;

EID: 38349155817     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2007.08.054     Document Type: Article

References (25)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
2. Sardari Nia P., Van Marck E., and Van Schil P. The prospect of biologic staging of non-small-cell lung cancer. Clin Lung Cancer 6 (2005) 217-224
3. Mountain C. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710-1717
4. Sardari Nia P., Colpaert C., Blyweert B., et al. Prognostic value of nonangiogenic and angiogenic growth patterns in non-small cell lung cancer. Br J Cancer 91 (2004) 1293-1300
5. Pezzella F., Pastorino U., Tagliabue E., et al. Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am J Pathol 151 (1997) 1417-1423
6. Pezzella F. Evidence of novel non-angiogenic pathway in breast-cancer metastasis. Lancet 355 (2000) 1787-1788
7. Vermeulen P.B., Colpaert C., Salgado R., et al. Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia. J Pathol 195 (2001) 336-342
8. Vermeulen P.B., Sardari Nia P., Colpaert C., et al. Lack of angiogenesis in lymph node metastases of carcinomas is growth pattern dependent. Histopathology 40 (2002) 105-107
9. Brambilla E., Travis W.D., Colby T.V., Corrin B., and Shimosato Y. The new World Health Organization classification of lung tumors. Eur Respir J 18 (2001) 1059-1068
10. Van den Eynden G., Van der Auwera I., Van Laer S., et al. Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumor in patients with breast cancer. Br J Cancer 93 (2005) 1128-1136
11. Chalkley H.W. Method for quantitative morphologic analysis of tissues. J Natl Cancer Inst 4 (1943) 47-53
12. Weidner N., Semple J.P., Welch W.R., and Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324 (1991) 1-8
13. Giatromanolaki A., Koukourakis M., Sivridis E., O′Byrne K., Gatter K.C., and Harris A.L. "Invading edge vs. inner" (edvin) patterns of vascularisation: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer. J Pathol 192 (2000) 140-149
14. Koukourakis M.I., Giatromanolaki A., Thorpe P.E., et al. Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer. Cancer Res 60 (2000) 3088-3095
15. Tanaka F., Ishikawa S., Yanagihara K., et al. Expression of angiopoietins and its clinical significance in non-small cell lung cancer. Cancer Res 62 (2002) 7124-7129
16. Offersen B., Pfeiffer P., Hamilton-Dutoit S., and Overgaard J. Patterns of angiogenesis in nonsmall-cell lung carcinoma. Cancer 91 (2001) 1500-1509
17. Hu J., Bianchi F., Ferguson M., et al. Gene expression signature for angiogenic and nonangiogenic non-small-cell lung cancer. Oncogene 24 (2005) 1212-1219
18. Vermeulen P.B., Gasparini G., Fox S.B., et al. Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumors. Eur J Cancer 38 (2002) 1564-1579
19. Giatromanolaki A., Koukourakis M., O'Byrne K., et al. Prognostic value of angiogenesis in operable non-small cell lung cancer. J Pathol 179 (1996) 80-88
20. Chandrachud L.M., Pendleton N., Chisholm D.M., Horan M.A., and Schor A.M. Relationship between vascularity, age and survival in non-small-cell lung cancer. Br J Cancer 76 (1997) 1367-1375
21. Fontanini G., Lucchi M., Vignati S., et al. Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study. J Natl Cancer Inst 89 (1997) 881-886
22. Pastorino U., Andreola S., Tagliabue E., et al. Immunocytochemical markers in stage I lung cancer: relevance to prognosis. J Clin Oncol 15 (1997) 2858-2865
23. Duarte I.G., Bufkin B.L., Pennington M.F., et al. Angiogenesis as a predictor of survival after resection for stage I non-small-cell lung cancer. J Thorac Cardiovasc Surg 115 (1998) 652-658
24. Matsuyama K., Chiba Y., Sasaki M., Tanaka H., Muraoka R., and Tanigawa N. Tumor angiogenesis as a prognostic marker in operable non-small-cell lung cancer. Ann Thorac Surg 65 (1998) 1405-1409
25. Ohta Y., Tomita Y., Oda M., Watanabe S., Murakami S., and Watanabe Y. Tumor angiogenesis and recurrence in stage I non-small cell lung cancer. Ann Thorac Surg 68 (1999) 1034-1038